Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care
Tóm tắt
Từ khóa
Tài liệu tham khảo
Tidemalm D, 2008, Excess mortality in persons with severe mental disorder in Sweden: a cohort study of 12 103 individuals with and without contact with psychiatric services, Clin Pract Epidemol Ment Health, 4, 23, 10.1186/1745-0179-4-23
Casadebaig F, 1999, Mortality in schizophrenia patients. 3 years follow‐up of a cohort, Encephale, 25, 329
Mental and Physical Health Platform., 2008, Mental and physical health charter. Bridging the gap between mental and physical health
Colton CW, 2006, Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states, Prev Chronic Dis, 3, A42
Newcomer JW, 2007, Antipsychotic medications: metabolic and cardiovascular risk, J Clin Psychiatry, 68, 8
Vreeland B, 2007, Treatment decisions in major mental illness: weighing the outcomes, J Clin Psychiatry, 68, 5
Parks J, 2006, Morbidity and mortality in people with serious mental illness
Lawrence D, Inequalities in health care provision for people with severe mental illness, J Psychopharmacol
Chan M, 2010, Equity, social determinants and public health programmes, 1
World Health Organization., 2003, Global strategy on diet, physical activity and health
Bray GA, 2008, In the clinic. Obesity, Ann Intern Med, 149, ITC4–1
National Institutes of Health, National Heart, Lung and Blood Institute., 1998, Clinical guidelines on the identification, evaluation and treatment of overweight and obesity in adults: the evidence report
International Diabetes Federation.The IDF consensus worldwide definition of the metabolic syndrome.http:www.idf.org.
Zhou BF, 2002, Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults. Study on optimal cut‐off points of body mass index and waist circumference in Chinese adults, Biomed Environ Sci, 15, 83
McElroy SL, 2006, Managing metabolic abnormalities in the psychiatrically ill: a clinical guide for psychiatrists, 55
Wirshing DA, 2004, Schizophrenia and obesity: impact of antipsychotic medications, J Clin Psychiatry, 65, 13
Citrome L, 2007, Risk‐benefit analysis of available treatments for schizophrenia, Psychiatric Times, 1, 27
Scheen A, 2008, Traitement neuroleptique et troubles metabolic, Med Mal Metabol, 2, 593
Hert M, Metabolic and endocrine adverse effects of second‐generation antipsychotics in children and adolescents: a systematic review of randomized, placebo controlled trials and guidelines for clinical practice, Eur Psychiatry
Barak Y, Switching to aripiprazole as a strategy for weight reduction: a meta‐analysis in patients suffering from schizophrenia, J Obes
Risselada AJ, Association between HTR2C gene polymorphisms and the metabolic syndrome in patients using antipsychotics: a replication study, Pharmacogenomics
Pacholczyk M, 2008, The metabolic syndrome. Part I: definitions and diagnostic criteria for its identification. Epidemiology and relationship with cardiovascular and type 2 diabetes risk, Postepy Hig Med Dosw, 62, 530
Bobes J, Cardiovascular and metabolic risk in outpatients with schizoaffective disorder treated with antipsychotics: results from the CLAMORS study, Eur Psychiatry
Rummel‐Kluge C, Head‐to‐head comparisons of metabolic side effects of second generation antipsychotics in the treatment of schizophrenia: a systematic review and meta‐analysis, Schizophr Res
Hert M, Metabolic parameters in the short‐ and long‐term treatment of schizophrenia with sertindole or risperidone, Eur Arch Psychiatry Clin Neurosci
Cavanagh MR, 2007, A UK audit of screening for the metabolic side effects of antipsychotics in community patients, Schizophr Bull, 33, 1397
World Health Organization Department of Noncommunicable Disease Surveillance., 1999, Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus
Whiting D, 2010, Equity, social determinant and public health programmes, 77
Hert M, The METEOR study of diabetes and other metabolic disorders in patients with schizophrenia treated with antipsychotic drugs. I. Methodology, Int J Methods Psychiatr Res
Baker RA, 2009, Atypical antipsychotic drugs and diabetes mellitus in the US Food and Drug Administration Adverse Event Database: a systematic Bayesian signal detection analysis, Psychopharmacol Bull, 42, 11
Sachs GS, 1999, Weight gain associated with use of psychotropic medications, J Clin Psychiatry, 60, 16
Department of Health., 2001, Diabetes national service framework
Wong JO, 2007, Olanzapine‐induced diabetic ketoacidosis in a Chinese man, Hong Kong Med J, 13, 73
Reddymasu S, 2006, Elevated lipase and diabetic ketoacidosis associated with aripiprazole, JOP, 7, 303
Aruna PAP, 1995, Chlorpromazine induced diabetes mellitus, J Assoc Physicians India, 43, 146
World Health Organization., 2009, Cardiovascular diseases (CVDs)
Mendis S, 2010, Equity, social determinants and public health programmes, 31
World Health Organization., 2002, The world health report 2002: reducing risks, promoting healthy life
Casey DE, 2004, Antipsychotic‐induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia, J Clin Psychiatry, 65, 4
Glassman A, 2011, Depression and heart disease
Nicol G, 2009, Preliminary results of the MEAC study: metabolic effects of antipsychotics in children, Schizophr Bull, 35, 32
Khawaja IS, 2009, Depression and coronary artery disease: the association, mechanisms, and therapeutic implications, Psychiatry, 6, 38
Pies RW, 2001, Antipsychotics: the heart of the problem, Psychiatric Times, 18, 26
Elbe D, 2010, How does this happen? Part I: mechanisms of adverse drug reactions associated with psychotropic medications, J Can Acad Child Adolesc Psychiatry, 19, 40
Ames D, 2002, Comment minimiser les risques associés à un allongement significatif de l'intervalle QTc chez les personnes souffrant de schizophrénie. Recommandations consensuelles du Cardiac Safety in Schizophrenia Group (CSISG), Encéphale, 28, 552
Strom BL, Comparative mortality associated with ziprasidone and olanzapine in real‐world use among 18,154 patients with schizophrenia: the Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC), Am J Psychiatry
Weiss AP, 2006, Treatment of cardiac risk factors among patients with schizophrenia and diabetes, Psychiatr Serv, 57, 1145, 10.1176/ps.2006.57.8.1145
Lee HK, 1992, HIV‐1 in inpatients, Hosp Commun Psychiatry, 43, 181
Meyer I, 1993, HIV seroprevalence among long‐stay patients in a state psychiatric hospital, Hosp Commun Psychiatry, 44, 282
Stewart DL, 1994, HIV seroprevalence in a chronically mentally ill population, J Natl Med Assoc, 86, 519
Dasananjali T, 1994, The prevalence of HIV infection among mentally ill offenders in Thailand, J Med Assoc Thai, 77, 257
Schwartz‐Watts D, 1995, Seroprevalence of human immunodeficiency virus among inpatient pre‐trial detainees, Bull Am Acad Psychiatry Law, 23, 285
Cournos F, 2005, Schizophrenia and comorbid human immunodeficiency virus or hepatitis C virus, J Clin Psychiatry, 66, 27
Hert M, Knowledge about HIV in people with schizophrenia. A general population comparison, Clinical Schizophrenia & Related Psychoses
Drake RE, 1989, Substance abuse among the chronic mentally ill, Hosp Commun Psychiatry, 40, 1041
Aruffo JF, 1990, Knowledge about AIDS among women psychiatric outpatients, Hosp Commun Psychiatry, 41, 326
Said WM, 2001, Prevalence of hepatitis B virus among chronic schizophrenia patients, East Mediterr Health J, 7, 526, 10.26719/2001.7.3.526
Kalkan A, 2005, Prevalence and genotypic distribution of hepatitis GB‐C/HG and TT viruses in blood donors, mentally retarded children and four groups of patients in eastern Anatolia, Turkey, Jpn J Infect Dis, 58, 222, 10.7883/yoken.JJID.2005.222
Rosenberg SD, 2010, Assessing the STIRR model of best practices for blood‐borne infections of clients with severe mental illness, Psychiatr Serv, 61, 885, 10.1176/ps.2010.61.9.885
Ohta Y, 1988, The epidemiological study of physical morbidity in schizophrenics — 2. Association between schizophrenia and incidence of tuberculosis, Jpn J Psychiatry Neurol, 42, 41
Zeenreich A, 1998, Recurrent tuberculosis in a psychiatric hospital, recurrent outbreaks during 1987–1996, Harefuah, 134, 168
Fisher II, 1996, Experience in using serological tests in detecting tuberculosis in patients with severe mental pathology, Probl Tuberk, 1, 19
Mishin VIu, 2008, New‐onset pulmonary tuberculosis patients with schizophrenia: course and efficiency of treatment, Probl Tuberk Bolezn Legk, 6, 6
Lönnroth K, 2010, Equity, social determinants and public health programmes, 219
Chen YH, Poor clinical outcomes among pneumonia patients with schizophrenia, Schizophr Bull
Volkov VP, 2009, Respiratory diseases as a cause of death in schizophrenia, Probl Tuberk Bolezn Legk, 6, 24
Hammerschmidt S, 2009, Lung cancer: current diagnosis and treatment, Dtsch Arztebl Int, 106, 809
Gulbinat W, 1992, Cancer incidence of schizophrenic patients. Results of record linkage studies in three countries, Br J Psychiatry, 18, 75, 10.1192/S0007125000297080
Dupont A, 1986, Psychiatric case registries in public health, 229
Wagner S, 1978, Breast cancer at a psychiatric hospital before and after the introduction of neuroleptic agents, Cancer Res, 38, 2703
Kanhouwa S, 1984, Phenothiazines and breast cancer, J Natl Med Assoc, 76, 785
MalikP.Cross‐sectional study of bone density in patients with schizophrenic or schizophreniform disease.Dissertation Leopold‐Franzens University Innsbruck 2001.
PeuskensJ PaniL deHertMet al.Antipsychotics and hyperprolactinemia. Unpublished paper.
Kasperek‐Zimowska B, 2008, Sexual disorders in schizophrenia — overview of research literature, Psychiatr Pol, 42, 97
Aizenberg D, 1995, Sexual dysfunction in male schizophrenic patients, J Clin Psychiatry, 56, 137
Gabay PM, 2006, Sexual behavior in patients with schizophrenia: a review of the literature and survey in patients attending a rehabilitation program, Vertex, 17, 136
Kinzl JF, 2009, Major depressive disorder, antidepressants and sexual dysfunction, Neuropsychiatry, 23, 134
Berner MM, 2007, Management of sexual dysfunction due to antipsychotic drug therapy, Cochrane Database Syst Rev, 1, CD003546
Montejo AL, 2001, Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 outpatients, J Clin Psychiatry, 62, 10
Fava M, 2002, Sexual functioning and SSRIs, J Clin Psychiatry, 63, 13
Kenkre AM, 2000, Oral health and treatment needs in institutionalized psychiatric patients in India, Indian J Dent Res, 11, 5
Velasco‐Ortega E, 2005, Temporomandibular disorders among schizophrenic patients. A case‐control study, Med Oral Patol Oral Cir Bucal, 10, 315
Clark DB, 2003, Dental care for the patient with bipolar disorder, J Can Dent Assoc, 69, 20
British Society for Disability and Oral Health.Oral health care for people with mental health problems — guidelines and recommendations.http:www.bsdh.org.uk.
Nielsen J, Determinants of poor dental care in patients with schizophrenia: a historical, prospective database study, J Clin Psychiatry
Kwan S, 2010, Equity, social determinants and public health programmes, 159
Hert M, Second‐generation antipsychotics and constipation: a review of the literature, Eur Psychiatry